- Home
- KROS vs NNOX Comparison
KROS vs NNOX Comparison
Compare KROS & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- NNOX
- Stock Information
- Founded
- KROS 2015
- NNOX 2018
- Country
- KROS United States
- NNOX Israel
- Employees
- KROS N/A
- NNOX N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- NNOX Medical Electronics
- Sector
- KROS Health Care
- NNOX Health Care
- Exchange
- KROS Nasdaq
- NNOX Nasdaq
- Market Cap
- KROS 461.6M
- NNOX 426.0M
- IPO Year
- KROS 2020
- NNOX 2020
- Fundamental
- Price
- KROS $11.47
- NNOX $5.41
- Analyst Decision
- KROS Buy
- NNOX Strong Buy
- Analyst Count
- KROS 11
- NNOX 2
- Target Price
- KROS $30.00
- NNOX $17.50
- AVG Volume (30 Days)
- KROS 953.9K
- NNOX 2.7M
- Earning Date
- KROS 05-07-2025
- NNOX 03-31-2025
- Dividend Yield
- KROS N/A
- NNOX N/A
- EPS Growth
- KROS N/A
- NNOX N/A
- EPS
- KROS N/A
- NNOX N/A
- Revenue
- KROS $3,550,000.00
- NNOX $10,680,000.00
- Revenue This Year
- KROS $16.65
- NNOX $22.38
- Revenue Next Year
- KROS $107.46
- NNOX $153.96
- P/E Ratio
- KROS N/A
- NNOX N/A
- Revenue Growth
- KROS 2250.99
- NNOX 10.79
- 52 Week Low
- KROS $9.78
- NNOX $5.19
- 52 Week High
- KROS $72.37
- NNOX $12.29
- Technical
- Relative Strength Index (RSI)
- KROS 44.86
- NNOX 35.38
- Support Level
- KROS $10.62
- NNOX $5.19
- Resistance Level
- KROS $12.28
- NNOX $5.65
- Average True Range (ATR)
- KROS 0.60
- NNOX 0.45
- MACD
- KROS 0.34
- NNOX -0.04
- Stochastic Oscillator
- KROS 51.20
- NNOX 13.93
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service.